Search Details

Word: longingly (lookup in dictionary) (lookup stats)
Dates: all
Sort By: most recent first (reverse)


Usage:

Although its year-long moratorium on property purchases in Allston will expire in two weeks, Harvard does not intend to purchase more real estate in the neighborhood in the coming months, according to University Executive Vice President Katharine N. Lapp...

Author: By Sofia E. Groopman, CRIMSON STAFF WRITER | Title: No More Allston Buys, Univ. Says | 4/28/2010 | See Source »

...idea of Western Avenue as a main street is a long-established, officially-accepted goal of the city of Boston,” said Allston resident Harry Mattison, citing the Boston Redevelopment Authority’s 2005 document “North Allston: Strategic Framework for Planning...

Author: By Sofia E. Groopman, CRIMSON STAFF WRITER | Title: No More Allston Buys, Univ. Says | 4/28/2010 | See Source »

...this case, reminding us of its startling proximity to our privileged community. Instead of dismissing it as a disease of the developing world, we should take this opportunity to recognize TB’s continued relevance on the public health advocacy agenda and engage with the actors that have long stalled progress...

Author: By Thomas J. Hwang | Title: To Be or not TB | 4/28/2010 | See Source »

...After a long period of decline, TB incidence has risen dramatically since the 1980s, despite the improvement of sanitary conditions, the development of anti-TB drugs in the 1950s, and the introduction of the World Health Organization’s directly-observed treatment short-course program for more effective treatment. In 1993, the WHO declared TB a global-health emergency, setting ambitious goals which it later conceded could not be met by 2003 or possibly even 2015. That is to say, the consequences from the years of inadequate treatment and low attention to disease control in resource-poor regions have...

Author: By Thomas J. Hwang | Title: To Be or not TB | 4/28/2010 | See Source »

Moving forward, progress in developing new drugs has long been stalled by a combination of inadequate funding, regulatory bottlenecks, and tepid support from the pharmaceutical industry. Thanks largely to years of advocacy and the establishment of innovative public-private partnerships spanning the two sectors, new drugs and new models of clinical development are finally in the pipeline. Instead of developing new drugs one-by-one, the Critical Path to TB Regimens Initiative would bring together drug developers, under a “patients-first” commitment, to test their compounds together as an entirely new four-drug combination?...

Author: By Thomas J. Hwang | Title: To Be or not TB | 4/28/2010 | See Source »

Previous | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | Next